Great West Life Assurance CO Syndax Pharmaceuticals Inc Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 20,662 shares of SNDX stock, worth $406,008. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,662
Previous 7,182
187.69%
Holding current value
$406,008
Previous $171,000
147.95%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SNDX
# of Institutions
202Shares Held
87.1MCall Options Held
268KPut Options Held
76.8K-
Black Rock Inc. New York, NY7.91MShares$155 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.34MShares$144 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.72MShares$112 Million9.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$94.3 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.89MShares$76.4 Million1.09% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.11B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...